2009
DOI: 10.1615/jenvironpatholtoxicoloncol.v28.i4.10
|View full text |Cite
|
Sign up to set email alerts
|

EDITORIALPandemic Preparedness for Swine Flu Influenza in the United States

Abstract: In March and early April 2009, Mexico experienced outbreaks of influenza caused by the H1N1 virus, which has spread throughout the world. With the pandemic of H1N1 infections, we have discussed in this scientific article strategies that should limit the spread of the influenza A (H1N1) virus in our country. Specific vaccines against the influenza H1N1 virus are being manufactured, and a licensed vaccine is expected to be available in the United States by mid-October 2009. However, some health-care workers may … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 7 publications
(12 reference statements)
0
8
0
Order By: Relevance
“…Sera from these patients contain α-N-acetylgalactosaminidase (Nagalase) that deglycosylates Gc protein, preventing it from converting to MAF, possibly contributing to immunosuppression. 52 After the outbreaks of H1N1 influenza in 2009, Edlich et al 53 strongly recommended that all health care workers and patients be tested and treated for vitamin D deficiency to prevent exacerbation cytokine responses and reducing Toll-like receptor (TLR) activation. 18 Studies in mice suggest that blocking TLR9 may have use in treating human sepsis.…”
Section: Antimicrobial Efficacy Against Different Infective Agentsmentioning
confidence: 99%
“…Sera from these patients contain α-N-acetylgalactosaminidase (Nagalase) that deglycosylates Gc protein, preventing it from converting to MAF, possibly contributing to immunosuppression. 52 After the outbreaks of H1N1 influenza in 2009, Edlich et al 53 strongly recommended that all health care workers and patients be tested and treated for vitamin D deficiency to prevent exacerbation cytokine responses and reducing Toll-like receptor (TLR) activation. 18 Studies in mice suggest that blocking TLR9 may have use in treating human sepsis.…”
Section: Antimicrobial Efficacy Against Different Infective Agentsmentioning
confidence: 99%
“…Recently, there has been a great deal of interest in the role played by VitD in host resistance to infection, and a number of scientific claims reported broad anti-infectious effects, potentially beneficial in people infected with influenza [ 13 , 55 , 56 ]. This emerging role of VitD in innate immunity results in two findings: the immune system is able to produce 1 α -hydroxylase, the enzyme that converts circulating VitD to its active form [ 57 60 ] and the active VitD produced in the immune system led to the production and regulation of antimicrobial peptides such as cathelicidin and defensin β 2 [ 13 , 61 ] which in turn inhibited replication of Mycobacterium tuberculosis , in vitro [ 62 ].…”
Section: Is Vitd a Potential Immune-enhancing Agent Against Influementioning
confidence: 99%
“…An additional benefit of Vitamin D is reduced proinflammatory cytokine production, which may play a protective role during infections that cause a cytokine storm [54]. To avoid worsening of respiratory infections, Edlich et al recommended that testing and treating vitamin D deficiency in health care providers and patients [55].…”
Section: Clinical Relevancementioning
confidence: 99%